PLX4032 and melanoma: resistance, expectations and uncertainty
- PMID: 21417847
- DOI: 10.1586/era.11.3
PLX4032 and melanoma: resistance, expectations and uncertainty
Similar articles
-
Efficacy of vemurafenib in a trametinib-resistant stage IV melanoma patient--letter.Clin Cancer Res. 2014 May 1;20(9):2498-9. doi: 10.1158/1078-0432.CCR-13-2349. Clin Cancer Res. 2014. PMID: 24789037 No abstract available.
-
Resistance patterns with tyrosine kinase inhibitors in melanoma: new insights.Curr Opin Oncol. 2012 Mar;24(2):150-4. doi: 10.1097/CCO.0b013e32834fca92. Curr Opin Oncol. 2012. PMID: 22316627 Review.
-
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.J Clin Oncol. 2011 Aug 1;29(22):3085-96. doi: 10.1200/JCO.2010.33.2312. Epub 2011 Mar 7. J Clin Oncol. 2011. PMID: 21383288 Free PMC article.
-
Community experience of vemurafenib for BRAF(V600) melanoma.Lancet Oncol. 2014 Apr;15(4):369-70. doi: 10.1016/S1470-2045(14)70079-8. Epub 2014 Feb 27. Lancet Oncol. 2014. PMID: 24582506 No abstract available.
-
Overcoming metastatic melanoma with BRAF inhibitors.Arch Pharm Res. 2011 May;34(5):699-701. doi: 10.1007/s12272-011-0521-5. Arch Pharm Res. 2011. PMID: 21656352 Review.
Cited by
-
New vitamin D analogs as potential therapeutics in melanoma.Expert Rev Anticancer Ther. 2012 May;12(5):585-99. doi: 10.1586/era.12.40. Expert Rev Anticancer Ther. 2012. PMID: 22594894 Free PMC article. Review.
-
Circ_0084043 promotes cell proliferation and glycolysis but blocks cell apoptosis in melanoma via circ_0084043-miR-31-KLF3 axis.Open Life Sci. 2020 Oct 22;15(1):774-786. doi: 10.1515/biol-2020-0071. eCollection 2020. Open Life Sci. 2020. PMID: 33817265 Free PMC article.
-
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development.Cell Oncol (Dordr). 2024 Jun;47(3):967-985. doi: 10.1007/s13402-023-00910-w. Epub 2023 Dec 19. Cell Oncol (Dordr). 2024. PMID: 38112979
-
Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melanoma lung metastasis.Pharm Res. 2012 Nov;29(11):3040-52. doi: 10.1007/s11095-012-0726-4. Epub 2012 Mar 13. Pharm Res. 2012. PMID: 22410804 Free PMC article.
-
lncRNA-ATB functions as a competing endogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma.Int J Oncol. 2018 Sep;53(3):1094-1104. doi: 10.3892/ijo.2018.4454. Epub 2018 Jun 25. Int J Oncol. 2018. PMID: 29956757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials